Cumberland Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.444; its P/E ratio is -3.64; Cumberland Pharmaceuticals is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 9.35M	$ 10.09M	$ 10.89M	$ 9.22M	$ 9.12M
Gross Profit	$ 7.82M	$ 8.32M	$ 9.37M	$ 7.97M	$ 6.47M
EBIT	$ -6.10M	$ -946.20K	$ 1.06M	$ 365.58K	$ -2.28M
EBITDA	$ -4.03M	$ 303.80K	$ 2.27M	$ 1.63M	$ -1.82M
Net Income Common Stockholders	$ -6.29M	$ -1.57M	$ 872.20K	$ 145.12K	$ -3.41M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 18.32M	$ 18.51M	$ 18.25M	$ 16.39M	$ 19.76M
Total Assets	$ 81.78M	$ 87.75M	$ 89.38M	$ 89.47M	$ 92.93M
Total Debt	$ 18.43M	$ 18.65M	$ 18.95M	$ 20.78M	$ 20.96M
Net Debt	$ 106.86K	$ 138.35K	$ 696.92K	$ 4.39M	$ 1.20M
Total Liabilities	$ 52.52M	$ 52.10M	$ 52.54M	$ 53.42M	$ 56.95M
Stockholders Equity	$ 29.60M	$ 35.99M	$ 37.16M	$ 36.36M	$ 36.27M
Cash Flow	-
Free Cash Flow	$ 953.40K	$ 1.14M	$ 5.30M	$ -1.28M	$ 2.00M
Operating Cash Flow	$ 1.04M	$ 1.24M	$ 5.40M	$ -1.10M	$ 3.64M
Investing Cash Flow	$ 260.64K	$ -95.07K	$ -305.78K	$ -442.09K	$ -640.77K
Financing Cash Flow	$ -1.49M	$ -882.60K	$ -3.28M	$ -1.78M	$ -2.78M

Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Income Statement >

Cumberland Pharmaceuticals Debt to Assets

Balance Sheet >

Cumberland Pharmaceuticals Cash Flow

Cash Flow >

Cumberland Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing